QQ客服 官方微博 反馈留言

浏览/检索结果: 共3条，第1-3条 帮助 限定条件 发表日期：2020     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Comparative Evaluation of Participation and Diagnostic Yield of Colonoscopy vs Fecal Immunochemical Test vs Risk-Adapted Screening in Colorectal Cancer Screening: Interim Analysis of a Multicenter Randomized Controlled Trial (TARGET-C) 期刊论文 AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 卷号: 115 作者:  Chen, Hongda;  Lu, Ming;  Liu, Chengcheng;  Zou, Shuangmei;  Du, Lingbin 收藏  |  浏览/下载：51/0  |  提交时间：2021/03/15 Phase I dose-escalation and expansion study of PARP inhibitor, fluzoparib (SHR3162), in patients with advanced solid tumors 期刊论文 CHINESE JOURNAL OF CANCER RESEARCH, 2020, 卷号: 32, 期号: 3, 页码: 370-+ 作者:  Li, Huiping;  Liu, Rongrui;  Shao, Bin;  Ran, Ran;  Song, Guohong 收藏  |  浏览/下载：23/0  |  提交时间：2020/12/24 Phase I  PARP inhibitor (fluzoparib)  solid tumor  pharmacokinetics  safety  antitumor activity   Enhancing cellular morphological changes and ablation of cancer cells via the interaction of drug co-loaded magnetic nanosystems in weak rotating magnetic fields 期刊论文 RSC ADVANCES, 2020, 卷号: 10, 期号: 25, 页码: 14471-14481 作者:  Wu, Tingting;  Zhang, Qian;  Hu, Huiping;  Yang, Fang;  Li, Ke 收藏  |  浏览/下载：15/0  |  提交时间：2020/12/16 NANOPARTICLES  TETRANDRINE  INHIBITION  RESISTANCE  APOPTOSIS  PATHWAYS  RELEASE  IRON